Inhibition of caspase proteases by CrmA enhances the resistance of human leukemic cells to multiple chemotherapeutic agents

Leukemia

Volumn 11, Issue 10, 1997, Pages 1665-1672

  Antoku, K ^a   Liu, Z ^a   Johnson, D E ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Caspase; Chemotherapy; CrmA; Protease

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE; DOXORUBICIN; ETOPOSIDE; INTERLEUKIN 1BETA CONVERTING ENZYME; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEINASE INHIBITOR; VIRUS PROTEIN;

ARTICLE; CELL CULTURE; CELL DEATH; CELL KINETICS; CONTROLLED STUDY; COWPOX VIRUS; DRUG SENSITIVITY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME SUBSTRATE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA CELL; NONHUMAN; PRIORITY JOURNAL; T CELL LEUKEMIA; VIRUS GENE;

EID: 0030694424     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400805     Document Type: Article

References (13)

1. Kaufman SH. Induction of endonucleolytic DNA cleavage in human myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anti-cancer drugs: a cautionary note. Cancer Res 1989; 49: 5870-5878.
2. Barry MA, Behnke CA, Eastman A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hypothermia. Biochem Pharmacol 1990; 40: 2353-2362.
3. Sen S, D'Incalci M. Apoptosis: biochemical events and relevance to cancer chemotherapy. FEBS Lett 1992; 307: 122-127.
4. Wood AC, Elvin P, Hickman JA. Induction of apoptosis by anticancer drugs with disparate modes of action: kinetics of cell death and changes in c-myc expression. Br J Cancer 1995; 71: 937-941.
5. Hickman JA, Potten CS, Merritt JA, Fisher TC. Apoptosis and cancer chemotherapy. Philos Trans R Soc Land B Biol Sci 1994; 345: 319-325.
6. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980; 284: 555-556.
7. Wyllie AH, Morris RG, Smith AL, Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 1984; 142: 67-77.
8. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-1462.
9. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J. Human ICE/CED-3 protease nomenclature. Cell 1996; 87: 171.
10. Ellis HM, Horvitz HR. Genetic control of programmed cell death in the nematode Caenorhabditis elegans. Cell 1986; 44: 817-829.
11. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J, Elliston KO, Ayala JM, Casano FJ, Chin J, Ding GJ-F, Egger LA, Gaffney EP, Limjuco G, Palyha OC, Raju SM, Rolando AM, Salley JP, Yamin T-T, Lee TD, Shively JE, MacCross M, Mumford RA, Schmidt JA, Tocci MJ. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 1992; 356: 768-774.
12. Cerretti DP, Kozlosky CJ, Mosley B, Nelson N, Van Ness K, Greenstreet TA, March CJ, Kronheim SR, Druck T, Cannizzaro LA, Heubner K, Black RA. Molecular cloning of the interleukin-1β converting enzyme. Science 1992; 256: 97-100.
13. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 1993; 75: 641-652.